Also known as Reyataz
Atazanavir , marketed under the trade name Reyataz by Bristol Myers, (formerly known as BMS-232632) is an antiretroviral drug of the protease inhibitor (PI) class. Like other antiretrovirals, it is used to treat infection of human immunodeficiency virus (HIV).Source: Wikipedia
Estimated Total Cost: $879.79 for an average of 28 days supply
Patients are most commonly prescribed atazanavir to treat human immunodeficiency virus infection (hiv), viral hepatitis, liver disease, and hepatitis due to a toxin.